Walgreen's Same-Store Sales Dive

pillsDrug store giant Walgreen Co. (NYSE: WAG) announced this morning that November same-store sales fell 6.2% year-over-year, primarily due to the impact of generic drug sales replacing sales of higher-priced brand-name drugs. Total sales fell 3.9% from $6.09 billion last year to $5.85 billion.

Pharmacy sales in November fell 4.7%, and same-store pharmacy sales fell 8.8%. Pharmacy sales accounted for 63.2% of monthly sales.

Walgreen did not specifically indicate any impact from its now-resolved dispute with Express Scripts Inc. (NASDAQ: ESRX). During the nine-month fight with Express Scripts, Walgreen's lost millions of customers, and as much as 60% of the total could be gone permanently to competitor CVS Caremark Corp. (NYSE: CVS). Walgreen did say that prescriptions filled at comparable stores fell by 2.9% in November following a 1.8% drop in October.

Walgreen stock is up 2.45% this morning, at $35.12 in a 52-week range of $28.53 to $37.35, even though virtually every metric reported today was down. Even the number of flu shots administered is lower this year.

Paul Ausick


Filed under: 24/7 Wall St. Wire, Retail, Services Tagged: CVS, ESRX, WAG
Read Full Story
  • DJI26791.3521.150.08%
    NASDAQ8153.2063.650.79%
  • NIKKEI 22522548.9056.220.25%
    Hang Seng26725.686.100.02%
    DAX12747.96114.360.91%
  • USD (PER EUR)1.12-0.0021-0.19%
    USD (PER CHF)1.01-0.0014-0.14%
    JPY (PER USD)108.550.19800.18%
    GBP (PER USD)1.30-0.0028-0.22%